Gesco

GESCO was founded in 1989 to invest in SME companies in the German Mittelstand, focusing on companies facing succession challenges and with ongoing growth potential. There are currently 17 companies in GESCO’s holding structure, with four of these added in the last 12 months. These companies are substantially focused on tool manufacturing and mechanical engineering with some plastics technology exposure too with a range of end markets addressed.

Equities

Equities by Sector

Sectors

Thematics

Latest

Hybrid Air Vehicles – Redefining air travel and air freight

The humanoid revolution walking your way: How robots are stepping out of science fiction

From gold to gold miners: Extracting higher returns in the current bull run

Audiovisual

Latest

Polar Capital Global Financials Trust – equity proposition

Herantis Pharma – executive interview

Take on Trusts – April 2025

About Edison

About Edison

Careers

Gesco (GSC1)

Climate: Creating multi-trillion investment opportunities

ConsumerWatch – Looking for a sign

Molten Ventures – executive interviews

The US government and Trump: Market implications

UK consumer sectors – What did Santa bring in 2024?

Why is gold hitting new highs?

Saba Capital campaign – Your vote matters

Market outlook: What lies ahead in 2025

Borussia Dortmund – executive interviews

UK equities: A generational opportunity?

Renewable energy developers – Creating value for investors

Healthcare-focused trusts: A sector on the mend

MediaWatch – One step forward, two steps back

ConsumerWatch – Don’t look down

A net zero perspective – Investing in sustainability, technology & innovation

Banco Angolano de Investimentos (BAI) – Money-centre bank with lending optionality

The art of measurement – Challenges in metrology

Vietnam Holding – Vietnam in the global digital race

US small-cap equities – Time to shine?

MediaWatch – Encouragements and frustrations

ConsumerWatch – The times they are a-changin’

Emerging markets – Worthy of consideration

Dynam Capital at the 2024 Vietnam ESG Conference

MediaWatch – Glimpses of positivity

ConsumerWatch – Give me a reason to love you

UK stock market – Scope for further upside in UK large-cap stocks

Listed private equity – Performing a balancing act

ConsumerWatch – At least someone loves me

MediaWatch – Rinse and repeat

Outlook for 2024: Life sciences – where has the conviction gone?

South African life assurers: Where is the growth?

Deutsches Eigenkapitalforum (EKF) 2023 consumer and media

Deutsches Eigenkapitalforum (EKF) 2023 technology

Deutsches Eigenkapitalforum (EKF) 2023 financials and investment companies

Deutsches Eigenkapitalforum (EKF) 2023 industrials

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

VolitionRx – Decoding the DNA of cancer

MediaWatch – Still waiting…

ConsumerWatch – Falling into the fall

Shades of the 1970s

The long and winding road

MediaWatch – Targeting the opportunities

ConsumerWatch – Making the most of the summer

ASCO 2023 key takeaways

IFRS 17: Impact on life assurance companies

MediaWatch – Vision On

ConsumerWatch – A Spring in the step

Quantum computing: A booming industry

Critical minerals: The investment vacuum

Crypto, are you dead yet?

UK housebuilders

European equities

Listed Private Equity

Lithium’s adolescence

Battery energy storage

MediaWatch – Screening well

Vietnamese equities: Due a comeback?

Machine learning in drug development

ConsumerWatch – January sales

Outlook for 2023: Biotechs remain central to novel drug development

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

Cell and gene therapies

Investment companies: Latin America is worthy of consideration